CSE/BBM (CSE/BBM)

Canadian Securities Exchange: CSE/BBM · CAD

CA$0.02

+0.00 (+50.0%)· Recorded snapshot

Market cap	8.7M
Revenue (ttm)	278.2K
Net income (ttm)	-1.1M
EPS (ttm)	-CA$0.00
Shares out	579.7M
Volume	8,000
Beta	2.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 278.2K
Net income (ttm): -1.1M
EPS (ttm): -CA$0.00
Market cap: 8.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-220.1

P25 n/aP50 n/aP75 n/a

ROIC-68.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/BBM indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CAD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-24
Enterprise value	CAD 9.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA09609Y1016
Last earnings date	2025-11-24
Last refreshed	2026-10-29
Market cap	CAD 8.7M
Next earnings date	2026-11-24
Price	CAD 0.02
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	cse/BBM
Website	https://blueberriesmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.39%
EV/Sales	32.65x
FCF / EV yield	-6.42%
FCF yield	-6.71%
Industry forward P/E	34.4x
P/B ratio	303.43x
P/S ratio	31.26x
Price / tangible book value	303.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-271.97%
EBITDA margin	-253.7%
Gross margin	55.17%
Operating margin	-271.97%
Pretax margin	-384.25%
ROA	-47.09%
ROA (5Y)	-38.73%
ROCE	-2,640.27%
ROE	-220.07%
ROE (5Y)	-152.22%
ROIC	-68.2%
SBC / revenue	3.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-13.05%
Gross profit growth (Q)	6.81%
Gross profit growth 3Y	4.79%
Net income growth years	0
Revenue growth	-36.68%
Revenue growth (Q)	-37.31%
Revenue growth (QoQ)	-15.11%
Revenue growth 3Y	-3.24%
Revenue growth 5Y	22.9%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 50,852
EBIT	CAD -756,650
EBITDA	CAD -705,798
EPS	CAD -0.00
FCF per share	CAD -0.00
Financing cash flow	CAD 394,764
Free cash flow	CAD -583,674
Free cash flow minus SBC	CAD -593,999
Gross profit	CAD 153,473
Net borrowing	CAD 394,764
Net cash flow	CAD -136,696
Net income	CAD -1.1M
Operating cash flow minus SBC	CAD -593,999
Operating income	CAD -756,650
Revenue	CAD 278,207
Stock-based compensation	CAD 10,325

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-55.16
Book value per share	CAD 0.00
Debt / equity	14.1
Long-term assets	CAD 386,564
Long-term liabilities	CAD 0
Net cash (debt)	CAD -389,172
Net cash / market cap	-4.48%
Net debt / equity	13.58
Piotroski F-Score	3
Property, plant and equipment	CAD 12,016
Shareholders' equity	CAD 28,658
Tangible book value	CAD 28,657
Tangible book value per share	CAD 0.00
Total assets	CAD 670,099
Total cash	CAD 14,769
Total debt	CAD 403,941
Total liabilities	CAD 641,441
WACC	17.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.28
Current assets	CAD 283,535
Current liabilities	CAD 641,441
Current ratio	0.44
Inventory turnover	0.86
Net working capital	CAD 31,266
Quick ratio	0.32
Working capital	CAD -357,906
Working capital turnover	2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.6%
Shareholder yield	-16.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.01
1D price change	50%
1Y price change	50%
1Y return CAGR	50.04%
1Y total return	50%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.01
3Y price change	-25%
3Y return CAGR	-9.14%
3Y total return	-25%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.02
52-week high date	2026-09-21
52-week low	CAD 0.01
52-week low date	2026-10-23
5Y price change	-78.57%
5Y return CAGR	-26.52%
5Y total return	-78.57%
6M price change	50%
6M total return	50%
All-time high	CAD 0.88
All-time high date	2019-03-21
All-time low	CAD 0.01
All-time low date	2023-11-30
Average true range (ATR)	CAD 0.00
Average volume	47.6K
Beta (1Y)	-4.48
Beta (2Y)	-2.07
Beta (5Y)	2.47
Change from 52-week high	-25%
Change from 52-week low	50%
Change from all-time high	-98.3%
Change from all-time low	200%
Change from open	0%
Day's gap	50%
Dollar volume	CAD 120
High price	CAD 0.02
Low price	CAD 0.02
Monthly RSI	47.39
Open price	CAD 0.02
Previous close	CAD 0.01
Price vs 150-day SMA	7.91%
Price vs 20-day SMA	4.9%
Price vs 200-day SMA	11.94%
Price vs 50-day SMA	9.49%
Relative volume	0.17
RSI	52.03
Sharpe ratio	2.06
Sharpe ratio (3Y)	1.4
Sharpe ratio (5Y)	1.08
Sortino ratio	4.03
Sortino ratio (3Y)	2.63
Sortino ratio (5Y)	2.01
Volume	8K
Weekly RSI	51.89
YTD price change	50%
YTD total return	50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	149.9M
Shares change (QoQ)	0%
Shares change (YoY)	16.6%
Shares held by insiders	14.37%
Shares outstanding	579.7M

Deeper analysis on CSE/BBM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/BBM report

Is a complete CSE/BBM research report available?

No complete published report is available for cse/BBM (CSE/BBM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/BBM (CSE/BBM)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/BBM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/BBM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/BBM

Frequently asked questions